|Bid||0.1050 x 5000|
|Ask||1.5000 x 500|
|Day's Range||0.3000 - 0.5590|
|52 Week Range||0.0700 - 1.1800|
|Beta (5Y Monthly)||-0.13|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Advanced Regenerative Associates, led by Dr. DeMarco, is dedicated to developing a line of cellular therapy products and devices to treat and mitigate the effects of diabetic wounds and skin ulcers for patients not responding to current standards of care.
EATONTOWN, NJ / ACCESSWIRE / March 11, 2021 / American CryoStem Corporation (OTC: CRYO) a clinical stage biotechnology company, global licensor and a pioneer in autologous cellular processing and therapies announced today that it has begun processing patient's adipose tissue and culturing mesenchymal stem cells (ATCell™), for use in its FDA approved IND Phase I Clinical Trial.The Company's autologous mesenchymal stem cell infusion therapy ("Investigational Drug") development is part of a single center study under the protocol entitled: ATCell™ Expanded Autologous, Adipose-Derived Mesenchymal Stem Cells Deployed via Intravenous Infusion for the Treatment of Post-Concussion Syndrome (PCS) in Retired Military and Athletes.
EATONTOWN, NJ / ACCESSWIRE / February 25, 2021 / American CryoStem Corporation (OTC PINK:CRYO), a clinical stage biotechnology company, global licensor and a pioneer in autologous cellular processing and therapies, announced today that it has entered into an Agreement with BioTherapeutic Labs Corp. (BTL) an FDA registered Umbilical Cord Tissue Manufacturing Company headquartered in Boca Raton, Florida.